Gabler’s strong position in the confectionery and pharmaceutical businesses builds on Coperion’s existing food and pharmaceutical capabilities. The acquisition will leverage Gabler Engineering’s key strategic technology and know-how to enhance and support Coperion’s strategic growth opportunities in the food and pharmaceutical industries.
“Food and pharmaceutical are among Coperion’s strategic growth end markets, and we believe this acquisition will help us continue to enhance our existing business by leveraging Gabler’s expertise, reputation, and brand recognition in the industry,” said Kevin Buchler, Coperion Division President Strategic Markets / Aftermarket Sales and Services. “We have strong relationships with several multinational corporations and adding Gabler’s key strategic technology and expertise enables us to create more value for our customers.”